Module

Colorectal Cancer Prevention

Source: Research Priorities in Colorectal Cancer: Recommendations of the Scientific Leadership Council in GI Cancer of the Coalition of Cancer Cooperative Groups

Colorectal Cancer Prevention

Faculty:

Axel Grothey, MD

CME CREDIT INFORMATION

Release Date: 09/05/07

Expiration Date: 09/04/08

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Registered Nurses: 0.7 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

List dietary and lifestyle factors known to decrease the risk of colorectal cancer
Discuss the use of nonsteroidal antiinflammatory drugs for the prevention of colorectal cancer
Describe the use of epigenetic alterations in the stratification of patients at risk for colorectal cancer

Topics covered include:

Aspirin and Colorectal Cancer Prevention
Nonaspirin Nonsteroidal Antiinflammatory Drugs and CRC Prevention
Stratification of CRC Risk
Future Directions in Chemoprevention
Priority Issues in CRC: Prevention

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.